US FDA concludes audit of Indoco's Rabale facility & IAS division with zero observations

Indoco Remedies said that the United States Food and Drug Administration (US FDA) successfully completed inspection of its API Kilo Lab manufacturing facility at Rabale, Navi Mumbai and Indoco Analytical Solutions (IAS) division.
Read The Rest at :